REGENERON PHARMACEUTICALS (REGN)
13F ownership of REGENERON PHARMACEUTICALS among the superinvestors tracked on fructus.finance, based on their latest quarterly SEC filings.
Price history
Loading...
Tracked holders
4
Combined value
$226M
New buyers this quarter
4
Superinvestors holding REGN
J
Jim Simons
Renaissance Technologies LLC · Q2 2026
$92M
0.13% of portfolio
J
Joel Greenblatt
Gotham Asset Management, LLC · Q2 2026
$66M
0.15% of portfolio
K
Ken Griffin
Citadel Advisors LLC · Q2 2026
$36M
0.00% of portfolio
R
Ray Dalio
Bridgewater Associates, LP · Q2 2026
$32M
0.13% of portfolio
Based on 13F filings submitted to the SEC, published with roughly 45 days of lag. Only long equity positions are captured. See our guide on how to read a 13F filing for more context, or browse the full superinvestor consensus.